Differences

This shows you the differences between two versions of the page.

--- home:diseases:cfs [06.12.2019] – [Recent research] sallieq
+++ home:diseases:cfs [07.06.2019] – [Evidence of infectious cause] sallieq
@@ Line 79: / Line 79: @@
 Patients with CFS showed abnormalities in 20 metabolic pathways. (({{pubmed>long:    27573827}}))
 =====Symptoms=====
@@ Line 148: / Line 150: @@
-Today scientific evidence provides a growing link between infectious agents and Chronic Fatigue Syndrome.
+Today scientific evidence may provide a link between infectious agents and Chronic Fatigue Syndrome.
+In October 2009, we reported the first direct isolation of infectious xenotropic murine leukemia virus-related virus (XMRV). In that study, we used a combination of biological amplification and molecular enhancement techniques to detect XMRV in more than 75% of 101 patients with chronic fatigue syndrome (CFS).(({{pubmed>long:21178474}}))
+[[http://sacfs.asn.au/download/XMRV%20-%20Supporting%20Online%20Material.pdf|Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome]]
 ===== Impairment of immune function =====
@@ Line 227: / Line 234: @@
 <mainarticle> [[home:patients:mp_duration|Length of the Marshall Protocol]]</article>
-The length of time it takes an MP patient to return to a given level of functionality seems to vary somewhat by disease. Diseases like CFS and Lyme may take longer. This may be because patients with these diseases tend to be sicker than most.
+The length of time it takes an MP patient to return to a given level of functionality seems to vary somewhat by disease. Diseases like CFS and Lyme are likely to take longer. This may be because patients with these diseases tend to be sicker than most.

home/diseases/cfs.txt · Last modified: 09.14.2022 by 127.0.0.1